| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.14 | 0.05 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | -0.087 | 0.05 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.05 |